The market size for active implantable medical devices was valued at USD 22.5 billion in 2023 and is projected to grow to USD 37.1 billion by 2030, with a compound annual growth rate of 7.5% from 2024 to 2030.
The occurrence of chronic illnesses is increasing, the population is rapidly aging, cardiovascular and neurological illnesses are becoming more dominant, and the implantable medicinal device tech is advancing. Apart from such reasons, the industry advance is aided by the increasing funding to develop technically advanced items, increasing acceptance of neurostimulators, and growing growth in and awareness regarding medical implants.
The rising aging population is one of the key reasons behind the development of this sector. According to the World Health Organization, 2 in 12 people worldwide will be 60 years old or more by 2030. By this time, the count of individuals who are 60 years and older will touch 1.4 billion from 1 billion in 2020. Furthermore, the number of people who are 80 years or older will triple in 2020–2050 and touch 426 million.
In 2023, the hospital category, based on end users, dominated the market. This can be credited to the huge aged population and the surging occurrence of chronic illness, the requirement for healthcare facilities is increasing.
Hospitals face an increased influx of patients, leading to greater demand for medical equipment used in patient monitoring, treatment, and diagnosis. Additionally, hospitals often provide specialized procedures and therapies necessitating specific equipment.
In 2023, based on product, the implantable cardioverter defibrillators category was the major contributor to the market. This growth can be credited to the growing count of people with cardiovascular diseases worldwide, the growing requirement for such life-saving apparatus in developing nations, and the arrival of tech technical innovations in such devices.
